Facing public and political wrath for steep price hikes on life-saving EpiPens, the devices’ manufacturer, Mylan, announced Monday that it will offer a cheap generic. But the generic isn’t that cheap. Since Mylan bought EpiPens in 2007, the company has increased the price from around $50 for a single pen to a little more than $600 for a two
EpiPen Maker Mylan Reveals Generic That’s Still Triple The Price
In yet another example of how Big Pharma hikes the prices of cheap drugs, Mylan CEO Heather Bresch has defended the price hikes, saying the company only received $274 of the total price for a twin-package while insurers, pharmacies and other parties divvy up the rest.